Prognostic Role of Serum IL-6 Levels in Bladder Cancer Patients and Hints of its Origin
Serum IL-6 is a strong predictor of poor survival rates and adverse pathologic features in BC patients. IL-6 concentrations in tumor tissue supernatant correlate with tumor stage. The role of IL-6 in theranostics of bladder cancer deserves more attention.
Authors
- Peter J. Siska (ORCID: https://orcid.org/0000-0002-1521-6213)
- Kathrin Renner (ORCID: https://orcid.org/0000-0002-7116-1368)
- Sebastian Kälble
- Simon Engelmann (ORCID: https://orcid.org/0000-0003-3810-3307)
- Maximilian Haas (ORCID: https://orcid.org/0000-0003-3132-0130)
- Roman Mayr (ORCID: https://orcid.org/0000-0003-1796-3260)
- Christoph Pickl
- Sonja-Maria Decking
- Renate Pichler (ORCID: https://orcid.org/0000-0001-5286-9048)
- Bas W.G. van Rhijn (ORCID: https://orcid.org/0000-0001-7837-0595)
- Miodrag Gužvić (ORCID: https://orcid.org/0000-0001-8089-3969)
- Maximilian Burger (ORCID: https://orcid.org/0009-0005-5013-9435)
- Emily Rinderknecht (ORCID: https://orcid.org/0009-0002-7283-5237)
- Felix Kasparbauer
Institutions
- Innsbruck Medical University (AT)
- Universität Innsbruck (AT)
- University Hospital Regensburg (DE)
- Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL)
- University of Regensburg (DE)
Publication Details
- Journal
- Clinical Genitourinary Cancer
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1016/j.clgc.2025.102378
- Citations
- 3
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.02